circRNA basic information
circBase ID: hsa_circ_0067717
Name: hsa_circ_RNF13
Synonym: circRNA_0067717
Host Gene: RNF13
Genomic location(hg19): chr3:149563797-149613347:+
Genomic location(hg38): chr3:149846010-149895560:+
Subcellular localization: nucleus and cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0015459
MONDO name: nasopharyngeal carcinoma
Disease details: nasopharyngeal carcinoma / NPC
Disease DO ID:
9261
Disease MeSH ID:
D00007727; D000077274
Disease NCIt ID:
C3871
Disease ICD11 ID:
1883313543
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

tumors

Cell lines:

CNE-1; HNE-2; CNE-1/P; CNE-1/T; HNE-2/P; HNE-2/T

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: TRIM41, p53
Associated microRNA: -
Biological function: Promotes paclitaxel chemoresistance of NPC cells, promotes proliferation, migration and invasion under paclitaxel treatment, and decreases paclitaxel-mediated apoptosis.
Molecular mechanism: circRNA_0067717 acts as a scaffold for TRIM41 and p53, enhances TRIM41-mediated p53 ubiquitination and degradation, decreases p53 protein levels, and thereby induces paclitaxel chemoresistance.
Biological pathway or process:

drug resistance (promotes); chemoresistance (promotes); apoptosis (inhibits); proliferation (promotes); migration (promotes); invasion (promotes); ubiquitination (promotes); p53 signaling (inhibits)

Detected method:
Q
H
M
Validation methods:

Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; Microarray; FISH / smFISH; IF (Immunofluorescence); Nuclear-Cytoplasmic Fractionation; RIP (RNA Immunoprecipitation); RNA Pull-Down; Co-IP; Transfection; MTT; EdU Staining; Annexin V/PI Flow Cytometry; Transwell Assay; Wound Healing Assay; In Vivo Animal Model; IHC (Immunohistochemistry); Western Blot; Bioinformatics Analysis

Clinical significance:

circRNA_0067717 may serve as a potential therapeutic target for NPC and targeting the circRNA_0067717-TRIM41-p53 complex may be a new therapeutic strategy for paclitaxel resistance in NPC.

Description:

hsa_circ_0067717/circRNA_0067717 is upregulated in paclitaxel-resistant NPC cell lines. It promotes paclitaxel chemoresistance by acting as a scaffold that brings TRIM41 and p53 together, enhancing TRIM41-mediated ubiquitination and degradation of p53. Blocking the TRIM41 or p53 binding regions on circRNA_0067717 restores p53 stability and increases paclitaxel sensitivity.

Confidence score:

0.852

Other information
Title:

circRNA_0067717 promotes paclitaxel resistance in nasopharyngeal carcinoma by acting as a scaffold for TRIM41 and p53.

Journal: Cellular oncology (Dordrecht, Netherlands)
Published: 2023
PubMed ID: 36705889
Study type:

biological research

Data availability: The material supporting the conclusion of this study has been included within the article.
Code availability: -